Palomino Laboratories PALX
OTC PALX
$15.97 +0.65 (+4.24%)
At close: Aug 17, 2026 · 4:00 PM UTC

Palomino Laboratories (PALX) Accumulated Expenses (2025)

Palomino Laboratories (PALX) posted Accumulated Expenses of $280771.0 for Q4 2025, down 52.06% sequentially from $585703.0 in Q3 2025.

Palomino Laboratories (PALX) Accumulated Expenses (2025) Analysis & Trends

Palomino Laboratories has reported Accumulated Expenses for 1 years, with the latest figure at $280771.0 in Q4 2025.

  • Quarterly Accumulated Expenses changed N/A year-over-year to $280771.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $280771.0 (changed N/A YoY) and the FY2025 annual result came in at $280771.0, changed N/A from the prior year.
  • Accumulated Expenses retreated to $280771.0 in Q4 2025 per PALX's latest filing, from $585703.0 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $585703.0 in Q3 2025 and troughed at $280771.0 in Q4 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 280,771.00
Sep 30, 2025 585,703.00